Medicina (Oct 2021)

COVID-19 and Alzheimer’s Disease: A Literature Review

  • Louis Hardan,
  • Dimitar Filtchev,
  • Ratiba Kassem,
  • Rim Bourgi,
  • Monika Lukomska-Szymanska,
  • Hassan Tarhini,
  • Fouad Salloum-Yared,
  • Davide Mancino,
  • Naji Kharouf,
  • Youssef Haikel

DOI
https://doi.org/10.3390/medicina57111159
Journal volume & issue
Vol. 57, no. 11
p. 1159

Abstract

Read online

There are a number of potential implications for the field of Alzheimer’s disease (AD) stemming from the global spread of “SARS-COV-2”. Many studies that were conducted by Cleveland Clinic researchers identified a link between COVID-19 infection and brain abnormalities seen in people with AD. This article explains the association between COVID-19 and AD and how people with AD are affected by COVID-19, whether directly or indirectly. First, this article begins by explaining AD and its types, then giving an overview about COVID-19, its symptoms and the associated complications. Then, direct and indirect consequences of COVID-19 on people experiencing AD are discussed briefly. Some management strategies are recommended at the end of this article in addition to a future perspective on this topic. This article concludes by summarizing the main points mentioned about the association between COVID-19 and AD.

Keywords